Patel Shruti R, St Pierre Frederique, Velazquez Ana I, Ananth Snegha, Durani Urshila, Anampa-Guzmán Andrea, Castillo Katerina, Dhawan Natasha, Oxentenko Amy S, Duma Narjust
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Division of Hematology and Oncology, Northwestern Medical Center, Chicago, Illinois, USA.
Oncologist. 2021 Sep;26(9):779-786. doi: 10.1002/onco.13871. Epub 2021 Jul 9.
The proportion of women in the field of hematology and oncology (H&O) has increased over recent decades, but the representation of women in leadership positions remains poor. In an effort to close the gender gap in academia, it is important to report on such inequities in hopes to close these gaps and improve career development.
We conducted a retrospective, observational study of published award recipients from 1994 to 2019 from the seven major H&O societies in the world. Gender was determined based on publicly available data. The χ and Cochran-Armitage tests were used for data analysis.
Of the 1,642 awardees over the past 26 years, 915 met inclusion criteria. Award recipients were overwhelmingly men (77.9%) and non-Hispanic White (84.7%). Women awardees received 30.3% of the humanistic and education-related awards, whereas only receiving 16.0% of basic science awards (p < .01). Women represent 35.6% of all hematologists and oncologists but only received 24.0% of awards given to these physicians (p = .004). Black, Hispanic, and Asian awardees represented 3.7%, 3.3%, and 6.8% of the total awardees, respectively.
From 1994 to 2019, women were less likely to receive recognition awards from the seven major H&O societies studied compared with men. We also observed a considerably low proportion of minority awardees across all oncology subspecialties. Further studies examining how selection criteria favor either gender would be warranted in order to achieve equal representation in academic awards.
In this study, women and minority groups were found to be underrepresented amongst award recipients. Significant disparities were seen in disciplines that have been historically male predominant, such as basic sciences. As awards on an international level enhance academic resumes and assist with career advancement, it is important that awards are being given in an equitable manner. First steps to promote diversity and inclusion in academic medicine is reporting of gender and racial disparities in various areas of academia.
近几十年来,血液学和肿瘤学(H&O)领域的女性比例有所增加,但担任领导职务的女性比例仍然很低。为了缩小学术界的性别差距,报告此类不平等现象以缩小差距并促进职业发展非常重要。
我们对1994年至2019年世界七大H&O学会已发表的奖项获得者进行了一项回顾性观察研究。根据公开可用数据确定性别。使用χ检验和 Cochr an-Armitage检验进行数据分析。
在过去26年的1642名获奖者中,915名符合纳入标准。获奖者绝大多数是男性(77.9%)且为非西班牙裔白人(84.7%)。女性获奖者获得了30.3%的人文和教育相关奖项,而仅获得16.0%的基础科学奖项(p <.01)。女性占所有血液学家和肿瘤学家的35.6%,但仅获得授予这些医生奖项的24.0%(p = 0.004)。黑人、西班牙裔和亚裔获奖者分别占总获奖者的3.7%、3.3%和6.8%。
1994年至2019年期间,与男性相比,女性获得所研究的七大H&O学会认可奖项的可能性较小。我们还观察到所有肿瘤学亚专业中少数族裔获奖者的比例相当低。有必要进行进一步研究,以考察选拔标准如何偏向某一性别,以便在学术奖项中实现平等代表权。
在本研究中,发现女性和少数群体在获奖者中代表性不足。在历史上以男性为主导的学科,如基础科学领域,存在显著差异。由于国际层面的奖项会提升学术履历并助力职业发展,以公平的方式颁发奖项很重要。促进学术医学领域多样性和包容性的第一步是报告学术界各个领域的性别和种族差异。